Cargando…

Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial

BACKGROUND: Malaria still remains the leading cause of childhood morbidity and mortality in Uganda. Interventions like malaria vaccines which reduce the malaria burden are needed in malaria endemic communities. There is need to establish baseline characteristics in vaccine trial study sites. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaddumukasa, Mark, Buwembo, William, Sekikubo, Musa, Naiwumbwe, Halima, Namusoke, Fatuma, Kiwuwa, Stephen, Oketch, Brenda, Noor, Ramadhani, Chilengi, Roma, Mworozi, Edison, Kironde, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232662/
https://www.ncbi.nlm.nih.gov/pubmed/25380673
http://dx.doi.org/10.1186/1756-0500-7-793
_version_ 1782344610204352512
author Kaddumukasa, Mark
Buwembo, William
Sekikubo, Musa
Naiwumbwe, Halima
Namusoke, Fatuma
Kiwuwa, Stephen
Oketch, Brenda
Noor, Ramadhani
Chilengi, Roma
Mworozi, Edison
Kironde, Fred
author_facet Kaddumukasa, Mark
Buwembo, William
Sekikubo, Musa
Naiwumbwe, Halima
Namusoke, Fatuma
Kiwuwa, Stephen
Oketch, Brenda
Noor, Ramadhani
Chilengi, Roma
Mworozi, Edison
Kironde, Fred
author_sort Kaddumukasa, Mark
collection PubMed
description BACKGROUND: Malaria still remains the leading cause of childhood morbidity and mortality in Uganda. Interventions like malaria vaccines which reduce the malaria burden are needed in malaria endemic communities. There is need to establish baseline characteristics in vaccine trial study sites. This study determined the following baseline malariometric indices: spleen rates, bed net use, malaria parasitaemia and malaria episodes in an inception cohort of children aged 12 – 60 months in Iganga district, Uganda. METHODS: In a longitudinal cohort study, 748 children were enrolled with 397 in an active follow up arm and 351 in a passive arm. The children in the two arms were followed for 6 months to determine the incidence of malaria episodes. RESULTS: The overall baseline spleen rate was 8.2% (61/748) among the study participants. Of the households surveyed, about 36% reported using bed nets and almost 30% of the users had insecticide-treated nets. 274 (36.6%) of the study participants had a history of fever in the past 24 hrs at the time of the baseline survey. All participants had a peripheral blood smear for malaria parasites done at enrollment with 76.8% having the asexual form of malaria parasites. The malaria episodes per child per year were 1.5 and 0.79 in the active and passive follow up arms respectively. CONCLUSIONS: There is a high prevalence of malaria asexual parasitaemia in children below five years. The bed net usage still remains low among this population. These baseline malariometric indices have important implication for malaria control interventions.
format Online
Article
Text
id pubmed-4232662
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42326622014-11-16 Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial Kaddumukasa, Mark Buwembo, William Sekikubo, Musa Naiwumbwe, Halima Namusoke, Fatuma Kiwuwa, Stephen Oketch, Brenda Noor, Ramadhani Chilengi, Roma Mworozi, Edison Kironde, Fred BMC Res Notes Research Article BACKGROUND: Malaria still remains the leading cause of childhood morbidity and mortality in Uganda. Interventions like malaria vaccines which reduce the malaria burden are needed in malaria endemic communities. There is need to establish baseline characteristics in vaccine trial study sites. This study determined the following baseline malariometric indices: spleen rates, bed net use, malaria parasitaemia and malaria episodes in an inception cohort of children aged 12 – 60 months in Iganga district, Uganda. METHODS: In a longitudinal cohort study, 748 children were enrolled with 397 in an active follow up arm and 351 in a passive arm. The children in the two arms were followed for 6 months to determine the incidence of malaria episodes. RESULTS: The overall baseline spleen rate was 8.2% (61/748) among the study participants. Of the households surveyed, about 36% reported using bed nets and almost 30% of the users had insecticide-treated nets. 274 (36.6%) of the study participants had a history of fever in the past 24 hrs at the time of the baseline survey. All participants had a peripheral blood smear for malaria parasites done at enrollment with 76.8% having the asexual form of malaria parasites. The malaria episodes per child per year were 1.5 and 0.79 in the active and passive follow up arms respectively. CONCLUSIONS: There is a high prevalence of malaria asexual parasitaemia in children below five years. The bed net usage still remains low among this population. These baseline malariometric indices have important implication for malaria control interventions. BioMed Central 2014-11-08 /pmc/articles/PMC4232662/ /pubmed/25380673 http://dx.doi.org/10.1186/1756-0500-7-793 Text en © Kaddumukasa et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kaddumukasa, Mark
Buwembo, William
Sekikubo, Musa
Naiwumbwe, Halima
Namusoke, Fatuma
Kiwuwa, Stephen
Oketch, Brenda
Noor, Ramadhani
Chilengi, Roma
Mworozi, Edison
Kironde, Fred
Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial
title Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial
title_full Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial
title_fullStr Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial
title_full_unstemmed Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial
title_short Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial
title_sort malariometric indices from iganga, uganda: baseline characterization in preparation of gmz2 vaccine trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232662/
https://www.ncbi.nlm.nih.gov/pubmed/25380673
http://dx.doi.org/10.1186/1756-0500-7-793
work_keys_str_mv AT kaddumukasamark malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial
AT buwembowilliam malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial
AT sekikubomusa malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial
AT naiwumbwehalima malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial
AT namusokefatuma malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial
AT kiwuwastephen malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial
AT oketchbrenda malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial
AT noorramadhani malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial
AT chilengiroma malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial
AT mworoziedison malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial
AT kirondefred malariometricindicesfromigangaugandabaselinecharacterizationinpreparationofgmz2vaccinetrial